CEL-SCI CORPORATION Accounts Receivable
CEL-SCI CORPORATION (CVM) had Accounts Receivable of $0 as of 2022-09-30, per its 10-K filed 2022-12-27.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2022-12-27
- 2022-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $0.00.
- 2022-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $0.00.
- 2022-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $0.00.
- 2021-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $54.92K.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2022-09-30 | $0.00 10-K · filed 2022-12-27 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-12 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 |
| 2021-12-31 | $54.92K 10-Q · filed 2022-02-11 |
| 2021-09-30 | $54.92K 10-K · filed 2022-12-27 |
| 2021-06-30 | $54.92K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $54.92K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $54.92K 10-Q · filed 2021-02-12 |
| 2020-09-30 | $54.92K 10-K · filed 2021-12-21 |
| 2020-06-30 | $255.01K 10-Q/A · filed 2020-12-31 |
| 2020-03-31 | $62.29K 10-Q/A · filed 2020-12-30 |
| 2019-12-31 | $91.04K 10-Q/A · filed 2020-12-30 |
| 2019-09-30 | $62.77K 10-Q/A · filed 2020-12-31 |
| 2019-06-30 | $118.26K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $123.24K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $128.76K 10-Q · filed 2019-02-14 |
| 2018-09-30 | $118.66K 10-K/A · filed 2019-12-23 |
| 2018-06-30 | $119.65K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $136.78K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $47.61K 10-Q · filed 2018-02-12 |
| 2017-09-30 | $218.48K 10-K · filed 2018-12-19 |
| 2017-06-30 | $271.74K 10-Q/A · filed 2017-12-11 |
| 2017-03-31 | $4.25K 10-Q/A · filed 2017-12-11 |
| 2016-12-31 | $4.13K 10-Q/A · filed 2017-12-11 |
| 2016-09-30 | $394.51K 10-K · filed 2017-12-29 |
| 2016-06-30 | $790.66K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $654.83K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $378.27K 10-Q · filed 2016-02-09 |
| 2015-09-30 | $87.21K 10-K/A · filed 2017-12-11 |
| 2015-06-30 | $158.49K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $37.43K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $155.94K 10-Q · filed 2015-02-06 |
| 2014-09-30 | $81.82K 10-K · filed 2015-12-11 |
| 2014-06-30 | $80.44K 10-Q · filed 2014-08-08 |
| 2014-03-31 | $134.95K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $45.88K 10-Q · filed 2014-02-10 |
| 2013-09-30 | $74.26K 10-K · filed 2014-12-23 |
| 2013-06-30 | $163.74K 10-Q · filed 2013-08-09 |
| 2013-03-31 | $39.56K 10-Q · filed 2013-05-10 |
| 2012-12-31 | $14.90K 10-Q · filed 2013-02-08 |
| 2012-09-30 | $158.61K 10-K · filed 2013-12-27 |
| 2012-06-30 | $25.65K 10-Q · filed 2012-08-09 |
| 2012-03-31 | $101.46K 10-Q · filed 2012-05-10 |
| 2011-12-31 | $8.63K 10-Q · filed 2012-02-09 |
| 2011-09-30 | $457.34K 10-K · filed 2012-12-14 |
| 2011-06-30 | $414.13K 10-Q · filed 2011-08-09 |
| 2010-09-30 | $0.00 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |